Abbott Laboratories buy Daiwa Capital Markets
Start price
31.01.26
/
50%
€92.30
Target price
31.01.27
€95.29
Performance (%)
-10.86%
Price
17.04.26
€82.28
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.86%. This prediction currently runs until 31.01.27. The prediction end date can be changed by Daiwa_Capital_Market at any time. Daiwa_Capital_Market has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -3.766% | -3.766% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Daiwa_Capital_Market for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Daiwa Capital Markets from $136.00 to $113.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Daiwa_Capital_Market for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€110.72
21.10.25
21.10.25
€116.80
21.10.26
21.10.26
-25.69%
17.04.26
17.04.26
